UBS Group’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-183
| Closed | -$1K | – | 10413 |
|
|
2022
Q1 | $1K | Sell |
183
-922
| -83% | -$5.04K | ﹤0.01% | 9074 |
|
|
2021
Q4 | $4K | Buy |
1,105
+922
| +504% | +$3.34K | ﹤0.01% | 8501 |
|
|
2021
Q3 | $1K | Sell |
183
-3,113
| -94% | -$17K | ﹤0.01% | 8265 |
|
|
2021
Q2 | $20K | Buy |
3,296
+340
| +12% | +$2.06K | ﹤0.01% | 6277 |
|
|
2021
Q1 | $36K | Buy |
2,956
+6
| +0.2% | +$73 | ﹤0.01% | 5855 |
|
|
2020
Q4 | $43K | Buy |
2,950
+2,302
| +355% | +$33.6K | ﹤0.01% | 5331 |
|
|
2020
Q3 | $7K | Buy |
+648
| New | +$7K | ﹤0.01% | 6285 |
|